TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Share-based Compensation (2020 - 2026)

Updated

TScan Therapeutics' Share-based Compensation came in at $2.08 million for Q3 2026, down 31.0% from $3.01 million a year earlier and down 11.9% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, TScan Therapeutics reported Share-based Compensation of $8.91 million, down 28.2% year-over-year; for FY2025, it was $11.71 million, up 22.6% from FY2024.

  • Share-based Compensation has increased in each of the last five years, with a five-year compound annual growth rate of 86.8% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $9.55 million in FY2024 (+83.4%), $5.21 million in FY2023 (+14.4%), $4.55 million in FY2022 (+80.9%) and $2.52 million in FY2021 (+388.5%).
  • The five-year range for quarterly Share-based Compensation is $784,000 (Q4 2021) to $3.41 million (Q1 2025).
  • Year-over-year, Share-based Compensation has declined for four consecutive quarters, with growth averaging 12.5% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q4 2021 (growth of 422.7%), and the weakest in Q3 2026 (a decline of 31.0%).
  • Business Quant data shows TCRX's Share-based Compensation at $2.36 million (Q2 2026), $2.47 million (Q1 2026) and $2.01 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 372,681.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 200.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 357.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 160.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 369.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 234.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 2.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.08 Mn
Jun 30, 2026 2.36 Mn
Mar 31, 2026 2.47 Mn
Dec 31, 2025 2.01 Mn
Sep 30, 2025 3.01 Mn
Jun 30, 2025 3.27 Mn
Mar 31, 2025 3.41 Mn
Dec 31, 2024 2.71 Mn
Sep 30, 2024 2.52 Mn
Jun 30, 2024 2.33 Mn
Mar 31, 2024 1.98 Mn
Dec 31, 2023 1.50 Mn
Sep 30, 2023 1.34 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.15 Mn
Dec 31, 2022 1.30 Mn
Sep 30, 2022 1.25 Mn
Jun 30, 2022 1.02 Mn
Mar 31, 2022 984,000.00
Dec 31, 2021 784,000.00
API Access

TScan Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TCRX&period=max&api_key=YOUR_API_KEY